Patents by Inventor Andrew Gardner

Andrew Gardner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11966774
    Abstract: Methods, systems, and apparatus, including computer programs encoded on computer-readable media, for workflow generation using multiple interfaces. In some implementations, an interface for defining a workflow having one or more operations for a computer system to perform is provided. The interface can provide options that are selectable to cause an operation from a predetermined set of operations to be added to the workflow. Data indicating user selection of an option of the interface corresponding to a first operation in the predetermined set of operations is received. Code that specifies one or more custom operations is received. The workflow is defined to include (i) the first operation based on the data indicating the user selection and (ii) a second operation specified by the code.
    Type: Grant
    Filed: October 23, 2020
    Date of Patent: April 23, 2024
    Assignee: MicroStrategy Incorporated
    Inventors: Richard Gardner, Clayton Myers, Andrew Smith
  • Publication number: 20230115554
    Abstract: Assessment of cognitive function affected by brain injuries is achieved. This included, but is not limited to, assessment of cognitive function affected by brain injuries, for example injuries sustained during sporting activities. A virtual reality system is used to apply controlled cognitive loading to the subject, via a series of distinct test types which in combination apply an increasing cognitive load over time. Results are optionally assessed in conjunction with data from an instrumented mouthguard and/or Finite Element Analysis (FEA) model.
    Type: Application
    Filed: March 10, 2021
    Publication date: April 13, 2023
    Inventors: Mike Vegar, Ben Nizette, Thomas Rau, Andrew Gardner
  • Patent number: 11290291
    Abstract: In a Power over Data Lines (PoDL) system that conducts differential data and DC power over the same wire pair, various DC coupling techniques are described that improve DC voltage coupling while attenuating AC common mode noise and avoiding mode conversion. A first CMC and AC coupling capacitors are connected in series between a PHY and a twisted wire pair. A DC power supply is DC coupled to the wires via a series connection of a DMC and either matched inductors or a second CMC. Coupled between the DMC and the inductors/CMC is an RC termination circuit comprising a first capacitor coupled to one leg and a matched second capacitor coupled to the other leg. The two capacitors are connected to the same resistor coupled to ground.
    Type: Grant
    Filed: May 8, 2019
    Date of Patent: March 29, 2022
    Assignee: Analog Devices International Unlimited Company
    Inventors: Andrew Gardner, Gitesh Bhagwat
  • Patent number: 11258211
    Abstract: There is described a method of establishing an electrical connection through a flexible planar material. The method involves attaching an intermediate coupling element to the flexible planar material so as to align an aperture defined by the intermediate coupling element with a hole through the flexible planar material, and coupling an electrical connector to the intermediate coupling element so as to permit electrical connection through the flexible planar material. In this way, the intermediate coupling element can be attached to the garment during the garment manufacture process, and subsequently the electrical connector can be coupled to the intermediate coupling element separately from the main garment manufacture.
    Type: Grant
    Filed: October 21, 2020
    Date of Patent: February 22, 2022
    Assignee: AB CONNECTORS LTD.
    Inventors: Marcus Davies, Andrew Gardner, David Whitworth
  • Patent number: 10940155
    Abstract: A quetiapine fumarate composition for oral administration is provided comprising a pharmaceutically acceptable salt or solvate of quetiapine existing as a suspension in an aqueous carrier agent. The inventive liquid formulation demonstrates high bioavailability consistent with approved dosage forms, low agglomeration, reduced content of excipients commonly used in solid oral dosage forms and extended shelf life stability. Also provided is a method of manufacturing a liquid quetiapine suspension composition for oral administration and methods of administering therapeutically effective dosages of an oral liquid quetiapine suspension composition to patients in need thereof.
    Type: Grant
    Filed: February 6, 2020
    Date of Patent: March 9, 2021
    Assignee: TLC Therapeutics, LLC
    Inventors: Carl Tierney, Andrew Gardner, Jan Pick-Katolik, Stacey Powell, Mark Foley, Laurence Ramsey, Andrew Hardeman
  • Publication number: 20210057857
    Abstract: There is described a method of establishing an electrical connection through a flexible planar material. The method involves attaching an intermediate coupling element to the flexible planar material so as to align an aperture defined by the intermediate coupling element with a hole through the flexible planar material, and coupling an electrical connector to the intermediate coupling element so as to permit electrical connection through the flexible planar material. In this way, the intermediate coupling element can be attached to the garment during the garment manufacture process, and subsequently the electrical connector can be coupled to the intermediate coupling element separately from the main garment manufacture.
    Type: Application
    Filed: October 21, 2020
    Publication date: February 25, 2021
    Inventors: Marcus DAVIES, Andrew GARDNER, David WHITWORTH
  • Patent number: 10826252
    Abstract: There is described a method of establishing an electrical connection through a flexible planar material. The method involves attaching an intermediate coupling element to the flexible planar material so as to align an aperture defined by the intermediate coupling element with a hole through the flexible planar material, and coupling an electrical connector to the intermediate coupling element so as to permit electrical connection through the flexible planar material. In this way, the intermediate coupling element can be attached to the garment during the garment manufacture process, and subsequently the electrical connector can be coupled to the intermediate coupling element separately from the main garment manufacture.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: November 3, 2020
    Assignee: AB Connectors Ltd
    Inventors: Marcus Davies, Andrew Gardner, David Whitworth
  • Publication number: 20200179399
    Abstract: A quetiapine fumarate composition for oral administration is provided comprising a pharmaceutically acceptable salt or solvate of quetiapine existing as a suspension in an aqueous carrier agent. The inventive liquid formulation demonstrates high bioavailability consistent with approved dosage forms, low agglomeration, reduced content of excipients commonly used in solid oral dosage forms and extended shelf life stability. Also provided is a method of manufacturing a liquid quetiapine suspension composition for oral administration and methods of administering therapeutically effective dosages of an oral liquid quetiapine suspension composition to patients in need thereof.
    Type: Application
    Filed: February 6, 2020
    Publication date: June 11, 2020
    Inventors: Carl Tierney, Andrew Gardner, Jan Pick-Katolik, Stacey Powell, Mark Foley, Laurence Ramsey, Andrew Hardeman
  • Patent number: 10561669
    Abstract: A quetiapine fumarate composition for oral administration is provided comprising a pharmaceutically acceptable salt or solvate of quetiapine existing as a suspension in an aqueous carrier agent. The inventive liquid formulation demonstrates high bioavailability consistent with approved dosage forms, low agglomeration, reduced content of excipients commonly used in solid oral dosage forms and extended shelf life stability. Also provided is a method of manufacturing a liquid quetiapine suspension composition for oral administration and methods of administering therapeutically effective dosages of an oral liquid quetiapine suspension composition to patients in need thereof.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: February 18, 2020
    Assignee: TLC THERAPEUTICS, LLC
    Inventors: Carl Tierney, Andrew Gardner, Jan Pick-Katolik, Stacey Powell, Mark Foley, Laurence Ramsey, Andrew Hardeman
  • Publication number: 20200044875
    Abstract: In a Power over Data Lines (PoDL) system that conducts differential data and DC power over the same wire pair, various DC coupling techniques are described that improve DC voltage coupling while attenuating AC common mode noise and avoiding mode conversion. A first CMC and AC coupling capacitors are connected in series between a PHY and a twisted wire pair. A DC power supply is DC coupled to the wires via a series connection of a DMC and either matched inductors or a second CMC. Coupled between the DMC and the inductors/CMC is an RC termination circuit comprising a first capacitor coupled to one leg and a matched second capacitor coupled to the other leg. The two capacitors are connected to the same resistor coupled to ground.
    Type: Application
    Filed: May 8, 2019
    Publication date: February 6, 2020
    Inventors: Andrew Gardner, Gitesh Bhagwat
  • Patent number: 10366344
    Abstract: A computer-implemented method for selecting features for classification may include (1) generating a matrix X, a column vector Y, and a matrix Z from a training dataset that includes a plurality of samples with a plurality of features, (2) generating an augmented matrix from the matrix X, the column vector Y, and the matrix Z, (3) identifying one or more most-relevant features from the plurality of features by iteratively applying a sweep operation to the augmented matrix, and (4) training a classification model using the most-relevant features from the plurality of features rather than all of the plurality of features. Various other methods, systems, and computer-readable media may have similar features.
    Type: Grant
    Filed: March 31, 2016
    Date of Patent: July 30, 2019
    Assignee: Symantec Corporation
    Inventors: Nikolaos Vasiloglou, Jugal Parikh, Andrew Gardner
  • Patent number: 10250617
    Abstract: A computer-implemented method for detecting malware using machine learning may include (1) identifying data to be analyzed for malware, (2) classifying, using a classifier created by a combination of at least one deep learning neural network and at least one supervised data mining method, the data to be analyzed for malware, (3) determining, based on a predefined threshold, that the classification of the data indicates potential malware on the computing device, and (4) performing a security action based on the determination of potential malware on the computing device. Various other methods, systems, and computer-readable media are also disclosed.
    Type: Grant
    Filed: November 22, 2015
    Date of Patent: April 2, 2019
    Assignee: Symantec Corporation
    Inventors: Andrew Gardner, Walter Bogorad, Jun Mao
  • Patent number: 10177491
    Abstract: There is described a connector assembly having a first connector part and a second connector part. At least one of the first connector part and the second connector part comprises at least one magnet for providing an attractive force between the first connector part and the second connector part to align the first connector part and the second connector part in a connected state. The first connector part comprises a guide track and the second connector part comprises a follower, the guide track being shaped to guide movement of the follower, under the influence of said attractive force, to a retaining position in which the follower engages an abutment surface on the first connector part to provide a retaining mechanism for retaining the first connector part and the second connector part in the connected state.
    Type: Grant
    Filed: October 13, 2017
    Date of Patent: January 8, 2019
    Assignee: AB CONNECTORS LTD
    Inventors: Marcus Davies, Andrew Gardner, David Whitworth
  • Publication number: 20180360844
    Abstract: A quetiapine fumarate composition for oral administration is provided comprising a pharmaceutically acceptable salt or solvate of quetiapine existing as a suspension in an aqueous carrier agent. The inventive liquid formulation demonstrates high bioavailability consistent with approved dosage forms, low agglomeration, reduced content of excipients commonly used in solid oral dosage forms and extended shelf life stability. Also provided is a method of manufacturing a liquid quetiapine suspension composition for oral administration and methods of administering therapeutically effective dosages of an oral liquid quetiapine suspension composition to patients in need thereof.
    Type: Application
    Filed: February 23, 2018
    Publication date: December 20, 2018
    Inventors: Carl Tierney, Andrew Gardner, Jan Pick-Katolik, Stacey Powell, Mark Foley, Laurence Ramsey, Andrew Hardeman
  • Patent number: 10133071
    Abstract: Disclosed herein is a lens for a wearable projection system. The lens includes a lens blank and a holographic optical element. The holographic optical element can be removably attached to the lens. The holographic optical element is aligned to a position on the lens surface based on temporary alignment marks projected onto the lens.
    Type: Grant
    Filed: September 28, 2016
    Date of Patent: November 20, 2018
    Assignee: INTEL CORPORATION
    Inventor: Andrew Gardner Wade
  • Patent number: 10081799
    Abstract: This disclosure provides, among other things, a composition comprising: comprising a fusion protein comprising: (a) a DNA polymerase; and (b) a heterologous sequence-specific DNA binding domain. A method for copying a DNA template, as well as a kit for performing the same, are also described.
    Type: Grant
    Filed: February 14, 2017
    Date of Patent: September 25, 2018
    Assignee: New England Biolabs, Inc.
    Inventors: Pei-Chung Hsieh, Luo Sun, Thomas C. Evans, Jr., Theodore B. Davis, Andrew Gardner
  • Patent number: 10041051
    Abstract: This disclosure provides, among other things, a composition comprising: comprising a fusion protein comprising: (a) a DNA polymerase; and (b) a heterologous sequence-specific DNA binding domain. A method for copying a DNA template, as well as a kit for performing the same, are also described.
    Type: Grant
    Filed: February 14, 2017
    Date of Patent: August 7, 2018
    Assignee: New England Biolabs, Inc.
    Inventors: Pei-Chung Hsieh, Luo Sun, Thomas C. Evans, Jr., Theodore B. Davis, Andrew Gardner
  • Publication number: 20180216098
    Abstract: This disclosure provides, among other things, a composition comprising: a 5? exonuclease; a strand-displacing polymerase; and optionally a single strand DNA binding protein and/or a ligase. A method for polynucleotide assembly to form a synthon, as well as a kit for performing the same, are also described.
    Type: Application
    Filed: August 27, 2015
    Publication date: August 2, 2018
    Applicant: New England Biolabs, Inc.
    Inventors: Pei-Chung Hsieh, Luo Sun, Thomas C. Evans, Jr., Theodore B. Davis, Andrew Gardner
  • Patent number: 10037425
    Abstract: Suspicious file prospecting activity is detected based on patterns of file system access. A user's file system access is monitored over a specific time period. A sequence of the file accesses (e.g., represented as path names) made by the user during the time period is recorded. Distances between the recorded file accesses are determined, for example as edit distances. A distance sequence is recorded, comprising a record of the determined distances. The distance sequence is reduced to one or more baseline statistics describing the pattern of the user's access of the file system during the given period of time. At least one subsequent anomaly in the user's access of the file system is detected, by comparing at least one subsequently calculated statistic representing at least one subsequent pattern of the user's file system access to the at least one baseline statistic.
    Type: Grant
    Filed: August 26, 2015
    Date of Patent: July 31, 2018
    Assignee: Symantec Corporation
    Inventors: Aleatha Parker-Wood, Andrew Gardner
  • Patent number: 9993486
    Abstract: A quetiapine fumarate composition for oral administration is provided comprising a pharmaceutically acceptable salt or solvate of quetiapine existing as a suspension in an aqueous carrier agent. The inventive liquid formulation demonstrates high bioavailability consistent with approved dosage forms, low agglomeration, reduced content of excipients commonly used in solid oral dosage forms and extended shelf life stability. Also provided is a method of manufacturing a liquid quetiapine suspension composition for oral administration and methods of administering therapeutically effective dosages of an oral liquid quetiapine suspension composition to patients in need thereof.
    Type: Grant
    Filed: June 19, 2017
    Date of Patent: June 12, 2018
    Assignee: TLC THERAPEUTICS, LLC
    Inventors: Carl Tierney, Andrew Gardner, Jan Pick-Katolik, Stacey Powell, Mark Foley, Laurence Ramsey, Andrew Hardeman